Industry Briefs: May 28, 2012 - Pharmaceutical Technology

Latest Issue

Latest Issue
PharmTech Europe

Industry Briefs: May 28, 2012
A roundup of additional company and people news from pharmaceutical and biopharmaceutical companies, their suppliers, and contract-service providers.

Company News

Bend Research has expanded its existing hot-melt extrusion capacity with the addition of an 18-mm Leistritz twin-screw mixer/extruder. Read More

Bristol-Myers Squibb formed the International Immuno-Oncology Network (II-ON), a global collaboration between industry and academia that aims to further the scientific understanding of immuno-oncology. Read More

FEI has launched its Living Lab for structural biology research on the campus of the National Institutes of Health. Read More

Mylan and Sunovion have entered into settlement agreements in the companies’ litigation relating to generic Brovana (arformoterol tartrate) and Xopenex (levalbuterol hydrochloride).

Recipharm secures financing for a EUR 90-million ($112 million) loan facility for further acquisition of niche CDMOs, investment in existing facilities, and building long-term partnerships with major pharmaceuticals companies. Read More

People News

Amgen has announced that Kevin W. Sharer has retired from his post as CEO and the company’s board of directors has appointed Robert A. Bradway his replacement. Read More

DSM has appointed Laura Parks as president and business unit director of finished-dosage business. Read More

Onyx Scientific has appointed Brian Jolly as its European business development director. Read More

Pfizer has named Olivier Brandicourt as president and general manager of its emerging markets and established products business units. Read More


blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
| Weekly

Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatcchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
Medicare Payment Data Raises Questions About Drug Costs
FDA Wants You!
A New Strategy to Tackle Antibiotic Resistance
Drug-Diagnostic Development Stymied by Payer Concerns
Obama Administration Halts Attack on Medicare Drug Plans

Click here